us earns caliper life sciences 110909
On the homepage
Petters
Out There
Vikings
Artcetera
Caliper Life Sciences' 3rd-quarter loss narrows on lower costs and expenses
Print this story
E-mail this story
Save to del.icio.us
Share on Facebook
Share on Digg
Minnesota business by the numbers
See Minnesota's top earning companies, CEOs and non-profits
More from Business
HOPKINTON, Mass. - Caliper Life Sciences Inc., which makes technologies used for drug development, said Monday its third-quarter loss narrowed on lower costs and charges.
For the period ended Sept. 30, Caliper reported lost $3.4 million, or 7 cents per share, compared with a loss of $5.4 million, or 11 cents per share, in the same period last year. Revenue fell 5 percent to $32.2 million from $34 million.
Meanwhile, costs and expenses fell 9 percent to $35.3 million on lower restructuring charges and research and development costs.
Looking ahead, the company said it expects fourth-quarter revenue between $34.5 million and $36.5 million. It expects full-year revenue between $127 million and $129 million.
Shares of Caliper rose 40 cents, or 19 percent, to $2.55 in afternoon trading. The stock has traded between 63 cents and $3.02 over the last 52 weeks.
Recent Business stories
Freight train hauling coal derails in southwest Houston, no injuries reported - November 9, 2009
Freight train hauling coal derails in southwest Houston, no injuries reported - A freight train carrying coal has derailed in southwest Houston. More
Blog: Patent Pending
Lights out at U energy conference. Irony police notified.
Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.
Comment on this story | Be the first to comment | Hide reader comments